justbacked

Biotechnology, Health Care, Medical, Therapeutics

Secretome Therapeutics

Secretome Therapeutics raised $30M in a Series A announced on May 27, 2026, led by RA Capital Management, TEDCO, University System of Maryland Momentum Fund, Parent Project Muscular Dystrophy, HEST. Since then it has posted 6 roles (5 still open), the first 113 days after it. With 5 open roles it is hiring more than 20% of the 226 Series A startups on JustBacked (median: 9). In total it has raised $60.8M over 6 rounds from 6 investors.

Roles posted per month since the round
  • September 20263
  • October 20263

From Secretome Therapeutics's own hiring system, by posting date. Tracked since Oct 4, 2026; roles that closed before then aren't counted.

Secretome Therapeutics is a clinical-stage cell therapy company that develops therapies for rare cardiac diseases.

Why join Secretome Therapeutics?

The bet: cells from neonatal donors can be made consistent and potent enough to treat rare heart disease at scale. If it pays off, cardiac cell therapy needs far fewer donors, and Secretome, a clinical-stage Dallas company, could set the standard. RA Capital Management and TEDCO backed its $30M Series A, bigger than six in ten rounds at its stage this half, and all four open roles are under 30 days old.

JustBacked's take, based on Secretome Therapeutics's own site and its funding and hiring data.

Series A · $30M · 178d agosecretometherapeutics.com

Hiring velocity

Open roles
5
Added, 30 days
+1
Added, 7 days
+0
Closed, 30 days
0
Raised
178 days ago
Led by
RA Capital Management, TEDCO, University System of Maryland Momentum Fund, Parent Project Muscular Dystrophy, HEST
Team size
11-50
HQ
Dallas, Texas, United States
Newest role
29d ago
Tracked since
Oct 4, 2026

Where they're hiring

Science2
Hardware2
Clinical1

Open roles at Secretome Therapeutics

Source: secretometherapeutics.com, checked daily.